Affinity Asset Advisors, LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Affinity Asset Advisors, LLC disclosed 77 US equity positions worth $644.5m in its Q3 2024 13F filing. The largest position was XENE at 7.0% of the reported book, followed by APGE and NUVALENT INC.
What did Affinity Asset Advisors, LLC own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | XENE XENON PHARMACEUTICALS INC | Healthcare | 7.0% | $45.0m | 1,144,021 | – | |
| 2 | APGE APOGEE THERAPEUTICS INC | Healthcare | 6.1% | $39.0m | 664,198 | – | |
| 3 | NUVALENT INC | 5.4% | $34.5m | 337,500 | – | ||
| 4 | ACLXGBX ARCELLX INC | 5.2% | $33.4m | 400,000 | – | ||
| 5 | ALKS ALKERMES PLC | Healthcare | 4.3% | $28.0m | 1,000,000 | – | |
| 6 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 3.9% | $25.2m | 1,400,000 | – | |
| 7 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 3.3% | $21.2m | 100,000 | – | |
| 8 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 3.2% | $20.4m | 400,000 | – | ||
| 9 | NRIX NURIX THERAPEUTICS INC | Healthcare | 3.0% | $19.3m | 860,399 | – | |
| 10 | VERA VERA THERAPEUTICS INC | Healthcare | 3.0% | $19.2m | 435,000 | – | |
| 11 | VRNA VERONA PHARMA PLC | 2.9% | $18.7m | 650,000 | – | ||
| 12 | AUTL AUTOLUS THERAPEUTICS PLC | Healthcare | 2.5% | $16.3m | 4,500,000 | – | |
| 13 | CNTA CENTESSA PHARMACEUTICALS PLC | 2.4% | $15.4m | 965,612 | – | ||
| 14 | INOZYME PHARMA INC | 2.3% | $14.8m | 2,822,318 | – | ||
| 15 | SYRE SPYRE THERAPEUTICS INC | 2.3% | $14.7m | 498,420 | – | ||
| 16 | OMEROS CORP | 2.3% | $14.6m | 21,525,000 | – | ||
| 17 | KURA KURA ONCOLOGY INC | Healthcare | 2.1% | $13.4m | 687,785 | – | |
| 18 | COHERUS BIOSCIENCES INC | 2.0% | $13.1m | 16,625,000 | – | ||
| 19 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 1.9% | $12.6m | 290,447 | – | |
| 20 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 1.9% | $11.9m | 525,000 | – | |
| 21 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 1.8% | $11.5m | 1,400,000 | – | |
| 22 | KARYOPHARM THERAPEUTICS INC | 1.5% | $9.6m | 12,250,000 | – | ||
| 23 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 1.3% | $8.6m | 349,836 | – | |
| 24 | RZLT REZOLUTE INC | 1.3% | $8.2m | 1,700,000 | – | ||
| 25 | MERUS N V | 1.3% | $8.1m | 161,741 | – | ||
| 26 | CATBUSD ASTRIA THERAPEUTICS INC | 1.2% | $8.0m | 725,106 | – | ||
| 27 | ONC BEIGENE LTD | Healthcare | 1.2% | $7.9m | 35,000 | – | |
| 28 | NEWAMSTERDAM PHARMA COMPANY | 1.2% | $7.8m | 472,390 | – | ||
| 29 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 1.2% | $7.6m | 300,000 | – | |
| 30 | CLYM ELIEM THERAPEUTICS INC | 1.2% | $7.6m | 1,500,000 | – | ||
| 31 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 1.1% | $7.2m | 80,000 | – | |
| 32 | ERAS ERASCA INC | Healthcare | 1.1% | $6.8m | 2,499,431 | – | |
| 33 | GERN GERON CORP | Healthcare | 1.1% | $6.8m | 1,500,000 | – | |
| 34 | CATX PERSPECTIVE THERAPEUTICS INC | 1.0% | $6.7m | 500,000 | – | ||
| 35 | IMVT IMMUNOVANT INC | Healthcare | 1.0% | $6.4m | 225,000 | – | |
| 36 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 1.0% | $6.3m | 325,000 | – | |
| 37 | PCVX VAXCYTE INC | Healthcare | 0.9% | $5.7m | 50,000 | – | |
| 38 | ARVN ARVINAS INC | Healthcare | 0.9% | $5.5m | 225,000 | – | |
| 39 | 430 TERNS PHARMACEUTICALS INC | 0.8% | $5.0m | 600,000 | – | ||
| 40 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 0.7% | $4.7m | 147,500 | – | ||
| 41 | CGEM CULLINAN THERAPEUTICS INC | Healthcare | 0.7% | $4.4m | 263,817 | – | |
| 42 | TVTX TRAVERE THERAPEUTICS INC | 0.7% | $4.3m | 5,000,000 | – | ||
| 43 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 0.7% | $4.2m | 125,000 | – | |
| 44 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.7% | $4.2m | 350,000 | – | |
| 45 | INSM INSMED INC | Healthcare | 0.6% | $3.6m | 50,000 | – | |
| 46 | PERCEPTIVE CAP SOLUTIONS COR | 0.5% | $3.5m | 350,000 | – | ||
| 47 | NXTC NEXTCURE INC | 0.5% | $3.2m | 2,302,598 | – | ||
| 48 | SVRA SAVARA INC | Healthcare | 0.5% | $3.0m | 700,000 | – | |
| 49 | NKTX NKARTA INC | Healthcare | 0.5% | $2.9m | 650,000 | – | |
| 50 | MIRM MIRUM PHARMACEUTICALS INC | Healthcare | 0.5% | $2.9m | 75,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.